Clinical Trial Update: Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy. [Phase 2]

View source ↗

Summary

A Phase 2 randomized, open-label study comparing dideoxycytidine (zalcitabine, ddC) to zidovudine (AZT) in patients with AIDS or advanced HIV infection who had …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Hivid (zalcitabine)
• RETROVIR (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED